nad has been researched along with Bone Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aguennouz, M; Alibrandi, A; Allegra, A; Allegra, AG; Di Giorgio, RM; Innao, V; Musolino, C; Oteri, G; Oteri, R; Polito, F | 1 |
| Zainabadi, K | 1 |
| Gu, DR; Kim, HJ; Kim, MS; Lee, JN; Lee, SH; Oh, GS | 1 |
1 review(s) available for nad and Bone Diseases
| Article | Year |
|---|---|
Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders?
Topics: Animals; Bone Development; Bone Diseases; Bone Remodeling; Humans; Longevity; NAD; Sirtuin 1 | 2019 |
2 other study(ies) available for nad and Bone Diseases
| Article | Year |
|---|---|
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma.
Topics: Aged; Biomarkers; Bone Diseases; Case-Control Studies; Female; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Healthy Volunteers; Humans; Hydrogen Peroxide; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Myeloma; NAD; Oxidation-Reduction; Oxidative Stress; Sirtuin 2; Sirtuin 3 | 2021 |
The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis.
Topics: AMP-Activated Protein Kinases; Animals; Bone Diseases; Cell Differentiation; Cell Survival; Gene Expression Profiling; Mice; Mice, Inbred C57BL; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proto-Oncogene Proteins c-fos; RANK Ligand; Real-Time Polymerase Chain Reaction | 2017 |